Clinical events in a long-term prospective neonatal cohort of children with sickle cell disease: Evidence for a high disease burden without systematic preventive intensification with hydroxyurea

Am J Hematol. 2023 Dec;98(12):E395-E398. doi: 10.1002/ajh.27142. Epub 2023 Oct 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anemia, Sickle Cell* / complications
  • Anemia, Sickle Cell* / drug therapy
  • Antisickling Agents / therapeutic use
  • Child
  • Cost of Illness
  • Humans
  • Hydroxyurea* / therapeutic use
  • Infant, Newborn
  • Prospective Studies

Substances

  • Hydroxyurea
  • Antisickling Agents